Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target
Therapeutic strategies for the treatment of any severe disease are based on the discovery and validation of druggable targets. The human genome encodes only 600–1500 targets for small-molecule drugs, but posttranslational modifications lead to a considerably larger druggable proteome. The spontaneou...
Main Authors: | Sergio Enríquez-Flores, Luis Antonio Flores-López, Itzhel García-Torres, Ignacio de la Mora-de la Mora, Nallely Cabrera, Pedro Gutiérrez-Castrellón, Yoalli Martínez-Pérez, Gabriel López-Velázquez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/7/1050 |
Similar Items
-
Molecular Aging of Triosephosphate Isomerase
by: Yüksel, K. Umit
Published: (1987) -
Inhibition of triosephosphate isomerase by phosphoenolpyruvate in the feedback-regulation of glycolysis
by: Nana-Maria Grüning, et al.
Published: (2014-01-01) -
Isozymes of human triosephosphate isomerase: isolation and characterization
by: Sawyer, Thomas H.
Published: (1974) -
Isozymes and In Vivo Activity of Triosephosphate Isomerase
by: Snapka, Robert Morris
Published: (1974) -
Probing the Role of Highly Conserved Residues in Triosephosphate Isomerase : Biochemical & Structural Investigations
by: Bandyopadhyay, Debarati
Published: (2018)